Introduction
============

Adequate tissue oxygenation is a major issue in the management of anesthesia and intensive care in hypoxemic or shock state patients. It can also prevent surgical wound infection[@b1-dddt-8-1161] or postoperative nausea and vomiting.[@b2-dddt-8-1161] It is usually obtained by using mechanical ventilation and increased fraction of inspired oxygen (FIO~2~). Other procedures include intravenous administration of oxygen (O~2~),[@b3-dddt-8-1161] enteral administration of O~2~,[@b4-dddt-8-1161],[@b5-dddt-8-1161] and enteral administration of water enriched in O~2~(O~2~ waters).[@b6-dddt-8-1161] The present experiment further explores this route of O~2~ supply and compares the effects of two types of O~2~ water to those of a placebo (100 mg versus \[vs\] 10 mg O~2~/L, respectively) administered intragastrically in anesthetized pigs. Enrichment in O~2~ was obtained by injection of O~2~ at high oxygen pressure (PO~2~) and by an electrolytic process[@b7-dddt-8-1161] (see Methods). It has been suggested that this process of enrichment in O~2~ generates water clathrates which are able to trap solutes such as O~2~[@b8-dddt-8-1161]--[@b10-dddt-8-1161] and can facilitate O~2~ diffusion along PO~2~ gradients. A previous study of this O~2~ water obtained by electrolytic process shows an improvement of mitochondrial respiration ex vivo, in oxidative saponin-skinned fibers isolated from soleus muscles of rats, for O~2~ concentration lower than 150 μmol/L (Zoll et al, unpublished data, 2012).

The purpose of the present experiment was to verify in vivo the ability of these O~2~ waters to improve O~2~ diffusion to the peripheral tissues, by monitoring the transcutaneous oxygen pressure (TcPO~2~), which is a convenient way to assess tissue oxygenation during anesthesia.[@b11-dddt-8-1161]--[@b14-dddt-8-1161] We hypothesized that in a condition of hemodynamic and respiratory stability, TcPO~2~ will be higher with the water enriched in O~2~ by electrolysis.

Methods
=======

Animals
-------

The experiments, which were conducted on three groups of 14 male pigs (Large White, 6 months old, 22.5±0.8 kg; no significant difference between the three groups) were carried out at Institut de recherche contre les cancers de l'appareil digestif -- European Institute of Telesurgery (IRCAD-EITS, University of Strasbourg, France). The protocol was conducted in accordance with the American Physiological Society's Guiding Principles in the Care and Use of Animals and was approved by the local Institutional Animal Ethics Authority (authorization number 67--147).

Study protocol
--------------

The animals were housed at the research facility, at constant temperature (21°C) and with a 12:12 day/night cycle, with food and water ad libitum for 3 days before the experiment. Following premedication with intramuscular ketamine (20 mg/kg) and azaperone (2 mg/kg), a 20-gauge catheter was placed in an ear vein for normal saline infusion at 5 mL/kg/h. The animals were intubated (Portex Blue Line 6 mm; Smith Medical, Kent, UK) under laryngoscopy after injection of propofol (2 mg/kg) and pancuronium (0.2 mg/kg). A 20G arterial catheter (Leader-cath, Vygon, Ecouen, France) was then placed in the femoral artery by Seldinger technique, and a venous catheter was inserted in an internal jugular vein and advanced into the right ventricle under continuous pressure monitoring. Anesthesia was maintained using isoflurane up to a maximum of 2.5% end-tidal concentration, with 21% oxygen delivered using a ventilator (Aisys Carestation; GE Healthcare, Little Chalfont, UK). Tidal volume was set at 10 mL/kg, with a 4 cm H~2~O positive end expiratory pressure (PEEP), and end tidal PCO~2~ was kept constant between 36 and 40 mmHg by adjusting the respiratory rate between 14 and 18 cycles/minute. Body temperature was maintained with an isolation blanket. For the administration of waters, an orogastric tube was also put in place, and the gastric content was aspirated before the beginning of the procedure.

Measurement
-----------

Heart rate, ECG, continuous arterial pressure, esophageal temperature (esophageal probe, Odam Physiogard SM 785™; Schiller, Baar, Switzerland), and oxygen consumption (VO~2~) (CPX, SensorMedics, Yorba Linda, CA, USA) were monitored throughout the experiment. Skin perfusion was explored from phase shift of a laser light beamed by a fiber optic on moving red blood cells (Doppler flowmetry, Periflux PF4; Perimed AB, Stockholm, Sweden). The laser Doppler flowmeter probe was placed on the internal portion of the right thigh. Although precise quantifications cannot be made, it has been shown that changes in skin microcirculation can be monitored with this technique during sedation or anesthesia.[@b15-dddt-8-1161],[@b16-dddt-8-1161]

Measurement of TcPO~2~ (Tina TCM4 series, Radiometer, Denmark) was performed on the internal portion of the right thigh, close to the Doppler flowmeter probe. For this purpose, following two calibrations, the electrode (heated at 43°C) was placed on the skin, which had been shaved and cleaned with alcohol. A stabilization period of 20 minutes (TcPO~2~ changes \<2 mmHg within 5 minutes) was allowed before recording basal preingestion values.

Water administered
------------------

Three types of water were used: remineralized water used as placebo and waters enriched in O~2~ by injection and electrolysis. The waters were prepared from demineralized water which was remineralized with Na^+^ (200 mg/L), SO~4~^2−^ (250 mg/L), and PO~4~^2−^ (240 mg/L). The water ingested as placebo was enriched in O~2~ by injection at a level of 10 mg O~2~/L (ie, close to the value at equilibrium with atmospheric O~2~ at sea level at the temperature of ingestion \[\~8 mg/L at 5°C--10°C\]).[@b17-dddt-8-1161] The two other waters were enriched at 100 mg O~2~/L (PO~2~ \~1,220--1,350 mmHg) by injection or the electrolytic process. In this process, the remineralized water was pumped between two electrodes separated by a membrane permeable to electrical charges but not to gases and the water enriched in O~2~, which was recovered on the negative electrode (pH =7.1--7.2, conductivity =750--770 μS/cm, 4,375--5,000 μmol O~2~/L) was used to prepare the final product, which was kept in glass bottles with a narrow neck. Upon opening, and keeping the bottle unagitated at 20°C, the half-life of the decrease in O~2~ content was 5.5 days. Accordingly, only negligible loss of O~2~ should be expected within the short delay (\<1 minute) between opening of the bottle and administration of the water. It is worth mentioning that Nestle et al[@b18-dddt-8-1161] also examined the disappearance of O~2~ from an O~2~ water with an initial content of \~100 mg/L using nuclear magnetic resonance relaxometry. The half-life measured was also large (\~100 minutes), although lower than that measured in the present experiment, probably because the water was poured in drinking beakers with a much larger and more ventilated surface for O~2~ to escape than that in a bottleneck.

The waters, which were prepared by Danone Research (Palaiseau, France), were administered through the orogastric tube. Each animal received 10 mL/kg of water.

Experimental procedure
----------------------

The animals were studied for 90 minutes following water administration (T0). At each measurement point blood samples were simultaneously drawn from the femoral artery and the right ventricle. The arteriovenous oxygen difference (avDO~2~ mL O~2~/dL) was calculated from arterial and venous O~2~ contents (in mL/dL of blood) computed as \[(1.34× \[Hb\] × SaO~2~) + (0.003× PO~2~)\], where \[Hb\] is the hemoglobin concentration in g/dL and SaO~2~ the saturation of hemoglobin.

At the end of experiments the gastric content was aspirated through the orogastric tube, \~3 g samples of skin and gracilis muscle were quickly dissected in the vicinity of the TcPO~2~ electrode, and the animal was killed by an intravenous injection of potassium chloride.

Water absorption and distribution
---------------------------------

Absorption and distribution in the body water pool of the waters administered were assessed using D~2~O in eight animals in each group. For this purpose, the waters were labeled by adding 10 mL of D~2~O/L in order to obtain a final deuterium to protium ratio (D/H) \~10,000 ppm (actual values: 9,276±135 ppm). The D/H ratio was then measured 1) in plasma (separated from the blood by centrifugation) at selected intervals following water administration, 2) in the gastric content recovered at the end of experiment, and 3) in fluids recovered from the skin and muscle samples after homogenization and centrifugation. The D/H ratio was measured by mass spectrometry in water purified from the various fluids by reverse lyophilization; ie, the sample is freeze-dried and the water removed in the process is recovered in a cold trap.

Statistical analysis
--------------------

Data are presented as mean ± SEM. After testing for normality and homogeneity of variance, data were compared using parametric (one-way or two-way analysis of variance) or nonparametric tests (Kruskal--Wallis). For each parameter, except blood gas, the reference mean during the basal period is the average of the values recorded over successive 2.5-minute intervals during the steady state period of 20 minutes. A *P* value \<0.05 was regarded as statistically significant. Statistical analysis was performed by GraphPad Prism 5.0.

Results
=======

As shown in [Table 1](#t1-dddt-8-1161){ref-type="table"}, heart rate, mean arterial pressure, PaO~2~, avDO~2~, and VO~2~ were stable throughout the experiment and not significantly different in the three groups. The temperature was also similar in the three groups and the small decrease did not reach statistical significance. Skin blood flow significantly decreased during the experiment in the three groups between T0 and T90 (*P*\<0.05) ([Table 1](#t1-dddt-8-1161){ref-type="table"}). [Figure 1](#f1-dddt-8-1161){ref-type="fig"} shows changes in TcPO~2~ vs the mean of basal preingestion. From minute 0 to 30 following water administration, TcPO~2~ was stable and not significantly different between the three groups. Beginning at minute 30, TcPO~2~ slowly but significantly decreased until the end of experiment in the three groups. However, when compared to the control group, the decrease in TcPO~2~ was significantly lower in animals that received the water enriched in O~2~ by the electrolytic process (two-way analysis of variance: main effect of time \[*P*\<0.001\] and water \[*P*\<0.001\]) ([Figure 1](#f1-dddt-8-1161){ref-type="fig"}).

No significant difference was observed between the three groups for plasma D/H observed in the basal period (149±1, 157±2, and 149±1 ppm before administration of the placebo and the waters enriched by injection and electrolysis, respectively), and for the progressive increase in plasma D/H over background values, following administration of waters labeled with D~2~O ([Figure 2](#f2-dddt-8-1161){ref-type="fig"}). Based on the actual D/H and volume of O~2~ water administered in the stomach, and on the D/H and volume of the fluid aspirated from the stomach at the end of experiment, the volume of water which was emptied in the small intestine was computed and was found not significantly different in the three groups ([Table 2](#t2-dddt-8-1161){ref-type="table"}). The D/H ratio in water purified from the skin and skeletal muscle at the end of experiment were also not significantly different, respectively, in the three groups, but the values were \~91%--92%, those simultaneously observed in plasma ([Table 2](#t2-dddt-8-1161){ref-type="table"}).

Discussion
==========

Results from the present experiment show that over the last hour of anesthesia, when compared to the placebo and the water enriched in O~2~ by injection, TcPO~2~ was maintained at a higher level with the water enriched in O~2~ by the electrolytic process. When compared to the placebo, the progressive reduction in TcPO~2~ observed between minute 30 and 90 was slightly smaller with both waters enriched in O~2~, and the difference was significant for the water enriched in O~2~ by electrolysis. This was not associated with any significant difference in water absorption and distribution. Indeed, no significant difference was observed for the amount of water emptied from the stomach, and the appearance of D~2~O in plasma was fast and similar in the three groups, suggesting that in contrast to what was observed for CO~2~,[@b19-dddt-8-1161] the presence of O~2~ in the stomach does not delay gastric emptying. In addition, the kinetics of plasma D/H was not significantly different in the three groups, with a large increase within the first \~20 minutes followed by a more progressive rise until the end of experiment. As for D~2~O appearance in muscle and skin, it was also remarkably similar in the three groups but slightly lagged behind D~2~O appearance in plasma. This result suggests that water ingested is well distributed to various body compartments. Due to technical reasons, there is a paucity of data on the kinetics of distribution of labeled water ingested or administered in the blood[@b20-dddt-8-1161] and we are not aware of any data concerning the skin. As for the skeletal muscle, Schwartz[@b21-dddt-8-1161] showed that in mice, the D/H in this tissue with a low perfusion at rest was slow to equilibrate with that in plasma and tends to plateau at about 90% of the plasma value for at least 30 minutes. Our data are well in line with this observation, and suggest that the perfusion was small in both skeletal muscle and skin.

During general anesthesia, the skin is a tissue of choice to monitor because it is readily accessible, quickly vasoconstricts under shock states, and is the last to be reperfused in shock and resuscitation states.[@b14-dddt-8-1161] Skin oxygenation can be monitored using TcPO~2~, which might better reflect PaO~2~ than SaO~2~.[@b22-dddt-8-1161] Indeed, TcPO~2~ is closely related to PaO~2~ during anesthesia[@b23-dddt-8-1161] and accurately reflects local ischemic suffering and global shock.[@b14-dddt-8-1161],[@b24-dddt-8-1161] It is also a sensitive and reliable index in the diagnosis of peripheral arterial disease.[@b25-dddt-8-1161] The location and temperature of the electrode might affect the value of TcPO~2~ recorded.[@b22-dddt-8-1161],[@b26-dddt-8-1161],[@b27-dddt-8-1161] For these reasons, we consistently positioned the electrode on the internal portion of the upper thigh and the electrode was heated at 43°C, which allows for a better diffusion of O~2~, probably by shifting to the right the HbO~2~ dissociation curve.[@b28-dddt-8-1161]

During the first 30 minutes following administration of water, TcPO~2~ remained fairly stable. In contrast, over the subsequent 60 minutes, TcPO~2~ values consistently decreased in the three groups. This was not related to a reduction in PaO~2~. Indeed, in spite of the low FiO~2~ value used (21% as found in atmosphere versus the higher values commonly used in general anesthesia \[30%--60%\]), PaO~2~ was stable over the duration of experiment ([Table 1](#t1-dddt-8-1161){ref-type="table"}). The progressive reduction in TcPO~2~ was, thus, probably due to vasoconstriction, and this was confirmed by the reduction in skin blood flow observed in the three groups. The reasons for this progressive reduction in skin blood flow are difficult to pinpoint. Ingestion of water and stomach distension can induce skin vasoconstriction.[@b29-dddt-8-1161],[@b30-dddt-8-1161] Although the amount of water administered was small (\~225±80 mL) and a large portion was transferred to the small intestine and absorbed, this mechanism cannot be excluded. Another hypothesis is that the significant decrease in skin blood flow is due to the low body temperature of the pigs documented at the start of the experiment and at all time points ([Table 1](#t1-dddt-8-1161){ref-type="table"}). This hypothermia is due to temperature regulation in the research facility, to ingestion of water at ambient temperature, and probably to the lack of efficacy of the isolation blanket. This experimental condition could be a limitation of this study, but it should be noted that hypothermia was comparable in the three groups, and that hypothermia is a condition often observed during general anesthesia.

The better tissue oxygenation observed with the water enriched by the electrolytic process cannot be accounted for by the low amount of O~2~ which was supplied in the small amount of O~2~ waters administered: 225 mL of O~2~ waters with 100 mg of O~2~/L provide only \~16 mL of O~2~ vs an average VO~2~ slightly larger than 100 mL/min in the 22.5 kg animals studied (\~5 mL/kg/min; see [Table 1](#t1-dddt-8-1161){ref-type="table"}). In addition, the same amount of O~2~ was supplied by the waters enriched in O~2~ by injection and the electrolytic process, and a better tissue oxygenation was only observed with the water enriched in O~2~ by the electrolytic process.

Although it is difficult to speculate on the basis of the limited data from the present pilot experiment, the better maintenance of skin oxygenation as tracked by TcPO~2~ with the water enriched in O~2~ by the electrolytic process is consistent with the claim that this enrichment process could stabilize O~2~ in solution, and favors its diffusion along PO~2~ gradients.[@b7-dddt-8-1161] This phenomenon can be due to the fact that the electrolytic process generates supramolecular water structures, or water clathrates,[@b9-dddt-8-1161] which can trap O~2~ molecules and could modify the local pressure/content relationship for O~2~[@b7-dddt-8-1161]. This has been previously described with hemoglobin-based oxygen carriers, which should reduce the intracapillary resistance of O~2~ transport, enhancing the supply of O~2~ to the tissue.[@b31-dddt-8-1161],[@b32-dddt-8-1161] The possibility that water clathrates can increase O~2~ delivery and correct hypoxemia has been investigated by Spears.[@b33-dddt-8-1161] Unfortunately, in this experiment, intravenous administration of water clathrates was associated with transient episodes of fall in oxygen saturation, probably due to pulmonary capillary occlusion because of formation of large bubbles (\>50 μm) generated by defects in the delivery system. In the study by Spears,[@b33-dddt-8-1161] O~2~ clathrate hydrates were produced at high pressures and low temperatures, but Ozeki and Otsuka have recently shown that these water superstructures can also be generated using a magnetic field[@b8-dddt-8-1161] and they could also be produced by the electrolytic process[@b7-dddt-8-1161] used in the present experiment.

Conclusion
==========

In this protocol, O~2~ water produced by electrolytic process lessens the decline of peripheral tissue oxygenation. Potential applications of O~2~ water could be an alternate way of oxygen supply, for treatment of chronic or acute hypoxia. In the field of intensive care medicine or anesthesia, the possibility to administer intravenously O~2~ fixed in clathrates in saline solution could lead to other indications similar to those advocated for lipidic oxygen-containing microparticles,[@b3-dddt-8-1161] like rescue of hypoxemic patients.

Danone Research provided the three types of waters used in this study, and also provided financial support for this work. An abstract of this work was presented at the 2012 ASA Annual Meeting in Washington (October 13--17, 2012; A410).
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![Changes versus baseline in TcPO~2~ from T0 to T90 in the three groups.\
**Notes:** TcPO~2~ decreased in the three groups but remained significantly higher (\**P*\<0.001) from T30 to T90 with the water enriched in O~2~ by electrolysis than in control. Values represent mean ± SEM.\
**Abbreviations:** SEM, standard error of the mean; T, time; TcPO~2~, transcutaneous oxygen pressure.](dddt-8-1161Fig1){#f1-dddt-8-1161}

![Plasma D/H ratio over the 90-minute period following ingestion of labeled water.\
**Notes:** Plasma D/H ratio: Δppm over baseline value before administration of water. D/H ratio increased significantly from T10 in the three groups. No significant difference was observed between the three groups for the progressive increase in plasma D/H over background values. Values represent mean mean ± SEM; n=8.\
**Abbreviations:** D/H, deuterium/protium; SEM, standard error of the mean.](dddt-8-1161Fig2){#f2-dddt-8-1161}

###### 

Data observed before and at 30-minute intervals following administration of the three waters

                                     Min                                                Placebo                                            Injection                                          Electrolysis
  ---------------------------------- -------------------------------------------------- -------------------------------------------------- -------------------------------------------------- --------------
  Temperature (°C)                   0                                                  35.6±0.3                                           35.7±0.3                                           35.8±0.4
  30                                 34.9±0.4                                           35.1±0.4                                           34.9±0.6                                           
  60                                 34.9±0.4                                           35.6±0.4                                           35.1±0.5                                           
  90                                 34.9±0.4                                           35.1±0.4                                           35.0±0.6                                           
  Heart rate (beats/min)             0                                                  87±7                                               77±5                                               78±6
  30                                 83±7                                               96±12                                              79±7                                               
  60                                 87±9                                               89±7                                               84±7                                               
  90                                 101±8                                              85±7                                               83±6                                               
  Mean arterial pressure (mmHg)      0                                                  53±2                                               52±2                                               55±2
  30                                 53±2                                               51±2                                               54±2                                               
  60                                 54±3                                               51±2                                               51±3                                               
  90                                 54±2                                               50±2                                               52±3                                               
  PaO~2~ (mmHg)                      0                                                  95.3±3.0                                           96.8±2.3                                           102.8±5.3
  30                                 97.5±4.5                                           102.8±8.3                                          108.8±8.3                                          
  60                                 96.0±5.3                                           104.3±8.3                                          104.3±9.0                                          
  90                                 99.0±6.0                                           108.0±6.8                                          105.8±7.5                                          
  avDO~2~ (mLO~2~/dL)                0                                                  27.8±2.5                                           28.1±1.7                                           29.5±2.3
  30                                 27.0±2.2                                           28.9±1.6                                           29.0±2.0                                           
  60                                 29.9±3.4                                           27.0±1.9                                           29.8±2.0                                           
  90                                 27.4±2.4                                           27.1±1.3                                           28.5±2.0                                           
  VO~2~ (mL/kg/min)                  0                                                  5.2±0.5                                            5.7±0.7                                            5.0±0.6
  30                                 4.9±0.6                                            6.0±0.7                                            5.2±0.7                                            
  60                                 5.4±0.6                                            6.0±0.8                                            5.1±0.8                                            
  90                                 5.5±0.6                                            5.5±0.8                                            5.0±0.5                                            
  Skin blood flow (perfusion unit)   0                                                  44±4                                               38±4                                               33±5
  30                                 38±4                                               32±5                                               31±5                                               
  60                                 34±4[\*](#tfn2-dddt-8-1161){ref-type="table-fn"}   28±4[\*](#tfn2-dddt-8-1161){ref-type="table-fn"}   25±3[\*](#tfn2-dddt-8-1161){ref-type="table-fn"}   
  90                                 30±4[\*](#tfn2-dddt-8-1161){ref-type="table-fn"}   23±2[\*](#tfn2-dddt-8-1161){ref-type="table-fn"}   22±3[\*](#tfn2-dddt-8-1161){ref-type="table-fn"}   

**Notes:** Values are presented as mean ± SEM.

*P*\<0.05 (T0 versus T60 and T0 versus T90 in each group).

**Abbreviations:** avDO~2~, arteriovenous oxygen difference; min, minutes; PaO~2~, partial oxygen pressure in the blood; SEM, standard error of the mean; T, time; VO~2~, oxygen uptake.

###### 

Volume of water emptied from the stomach and D/H ratio measured at 90 minutes in the three groups

                                         Placebo   Injection   Electrolysis
  -------------------------------------- --------- ----------- --------------
  Water emptied from the stomach (mL)    185±14    238±18      151±16
  Final D/H in water from plasma (ppm)   92±4      93±3        94±4
  D/H in water from skin (ppm)           78±5      67±3        77±4
  D/H in water from muscle (ppm)         74±5      65±4        77±4

**Notes:** Values are presented as mean ± SEM. D/H ratio given in ppm above background values. No significant differences were detected between the three groups.

**Abbreviations:** D/H, deuterium/protium; SEM, standard error of the mean.
